AmeriCann, Inc. Overview
Industry: Real Estate Services
Sector: Real Estate
AmeriCann, Inc. operates as a specialized cannabis company in the United States. It engages in the product manufacturing and greenhouse cultivation facilities for licensed cannabis business. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is headquartered in Denver, Colorado.
AmeriCann, Inc. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review AmeriCann, Inc. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
AmeriCann, Inc. Competitors
AmeriCann, Inc. operates in the Real Estate Services industry within the Real Estate sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans